Skip to main content
. 2021 Jul 22;36(5):1190–1203. doi: 10.3904/kjim.2020.634

Figure 2.

Figure 2

Overall survival (OS) of patients with the various myeloproliferative neoplasm subtypes. ET, essential thrombocythemia; PV, polycythemia vera; pre-PMF, prefibrotic/early primary myelofibrosis; PMF, primary myelofibrosis.